Page 74 - IJB-5-1
P. 74

REVIEW ARTICLE

           Of balls, inks and cages: Hybrid biofabrication of 3D

           tissue analogs


           Nicanor I. Moldovan *, Leni Moldovan , Michael Raghunath     3,4
                                                  2
                                1
           1 Departments of Biomedical Engineering, Indiana University - Purdue University at Indianapolis,  Surgery, IU School of
                                                                                         2
           Medicine, Indianapolis, IN, 46202, USA,  Center for Cell Biology and Tissue Engineering, Institute for Chemistry and
                                            3
           Biotechnology, Competence Center TEDD, Zurich University of Applied Sciences, CH - 8820 Wädenswil, Switzerland
                        4
           Abstract: The overarching principle of three-dimensional (3D) bioprinting is the placing of cells or cell clusters in the 3D
           space to generate a cohesive tissue microarchitecture that comes close to in vivo characteristics. To achieve this goal, several
           technical solutions are available, generating considerable combinatorial bandwidth: (i) Support structures are generated first,
           and cells are seeded subsequently; (ii) alternatively, cells are delivered in a printing medium, so-called “bioink,” that contains
           them during the printing process and ensures shape fidelity of the generated structure; and (iii) a “scaffold-free” version of
           bioprinting, where only cells are used and the extracellular matrix is produced by the cells themselves, also recently entered
           a phase of accelerated development and successful applications. However, the scaffold-free approaches may still benefit from
           secondary incorporation of scaffolding materials, thus expanding their versatility. Reversibly, the bioink-based bioprinting
           could also be improved by adopting some of the principles and practices of scaffold-free biofabrication. Collectively, we
           anticipate  that  combinations  of  these  complementary  methods  in  a  “hybrid”  approach,  rather  than  their  development  in
           separate technological niches, will largely increase their efficiency and applicability in tissue engineering.
           Keywords: Tissue engineering, scaffolds, scaffold-free, bioprinting

           *Correspondence to: Nicanor I. Moldovan, “Richard L. Roudebush” VA Medical Center,  Indiana University - Purdue University at Indianapolis,
           1481 W. 10  St. Room C6128, Indianapolis, IN 46202. Tel.: 317-988-2337; nimoldov@iupui.edu
                  th
           Received: October 31, 2018; Accepted: November 28, 2018; Published online: December 26, 2018

           Citation: Moldovan NI, Moldovan L, Raghunath M, 2019, Of balls, inks and cages: Hybrid biofabrication of three-dimensional
           tissue analogs. International Journal of Bioprinting, vol.5(1): 167. http://dx/doi.org/10.18063/ijb.v5i1.167

           1. Biofabrication of Tissue Analogs - The          shared to create synergies with an eclectic mix of techniques
           Main Approaches                                    for  reaching  specific  goals.  In  future,  the  combined  use
                                                              of the main approaches in biofabrication will likely lead
           Biofabrication, the three-dimensional (3D) assembly of   to more “hybrid” systems and subsequent expectations
           living cells in structured systems  , has evolved in the past   on appropriate instrumentation  . For this reason, in our
                                      [1]
                                                                                        [8]
           decades as the biological facet of additive manufacturing .   overview, we will discuss the strengths and weaknesses of
                                                          [2]
           Technically, biofabrication can be roughly divided into
           “bioprinting,” a technology akin to the classical use of   these approaches, according to their main features.  [9]
                                                                                        [1,4]
                       [3]
                                              [4]
           ink and paper  , and “tissue assembly”   , where other   Moroni  et al., Groll  et al.    and Moldovan   have
           techniques such as “tissue strands”   [5] , lamination of   noticed some confusion regarding the terminology in this
           “cell sheets”   or cell spheroid piercing-and-stringing  ,   field. Therefore, here we need to specify again what - in our
                                                         [7]
                      [6]
           have recently evolved. The purpose is to assemble cells   opinion - 3D Bioprinting is not: namely, it is not the mere
           into a living, functional system that serves for  in vitro  additive manufacturing (a.k.a. 3D printing) of implantable
           drug development and substance testing, or as an in vivo  materials which, by all intents and purposes, would be
           implantable tissue  . However, the boundaries between  “biomaterials”   [10] .  The implantation of such a material
                           [1]
           approaches are blurring, because they will be increasingly  aims either at total immunological inertia (sometimes
           Of balls, inks and cages: Hybrid biofabrication of 3D tissue analogs © 2019 N I. Moldovan , et al. This is an Open Access article distributed under the
           terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-
           commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
                                                                                                             1
   69   70   71   72   73   74   75   76   77   78   79